FindTrial
Sign In

Association between ALT, ALT/AST ratio and Urinary albumin in the patients with Type 2 Diabetic Nephropathy

Association between ALT, ALT/AST ratio and Urinary albumin in the patients with Type 2 Diabetic Nephropathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100051501
Enrollment
Unknown
Registered
2021-09-24
Start date
2021-09-24
Completion date
Unknown
Last updated
2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic nephropathy

Interventions

NC:None
T2DM+Non-DN group:None
T2DM+DN group:None

Sponsors

Affiliated Hospital of Zunyi MedicalUniversity
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Meet the 2020 Chinese Medical Association Diabetes and Diabetes Complications Diagnostic Standards.

Exclusion criteria

Exclusion criteria: 1. Secondary renal disease caused by severe infection, tumor, and autoimmune disease; 2. Fatty liver, hepatitis, bile duct disease, myocarditis, myocardial infarction and other diseases that lead to increased liver enzymes; 3. Recently taking hepatotoxic and nephrotoxic drugs; complicated with mental system diseases and blood system diseases; 4. Type 1 diabetes.

Design outcomes

Primary

MeasureTime frame
ALT;AST;—

Countries

China

Contacts

Public ContactLiao Xin

Affiliated Hospital of Zunyi MedicalUniversity

liaoxin8618@163.om+86 13595208618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026